Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of SIILPCV10 in Healthy Adults, Toddlers, and Infants
NCT02308540Phase 2Completed
- Sponsor
- PATH
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of SIILPCV10 in pneumococcal disease, sponsored by PATH. Started Jan 2015; status: completed.
02
Drugs
SIILPCV10
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT02308540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308540.